Adcock Ingram Holdings | AIP - Los Gastos Financieros De La Deuda



Los Gastos Financieros De La Deuda Cambio Fecha
Akebia Therapeutics 4.83M 359.32M 2025-12
Alaunos Therapeutics USD 1.07M 215K 2023-06
Aspen Pharmacare ZAR 631.5M 301.5M 2024-06
Avita Medical AUD 1.25M 100K 2025-06
Dianthus Therapeutics USD 4.44M 263K 2024-09
Ionis Pharmaceuticals USD 18M 0 2025-12
IQVIA Holdings USD 193M 4M 2025-12
Life Healthcare ZAR 431M 107M 2022-12
Moderna USD 12.14B 12.13B 2025-09
Netcare ZAR 439M 51M 2022-12
Organon & Co USD 128M 3M 2025-09
Revvity USD 23.51M 742K 2025-12
Tectonic Therapeutic USD 12K 276.99M 2025-12
Viatris USD 119.6M 0 2025-12
Xeris Pharmaceuticals USD 7.15M 115K 2025-12